(Q42167855)

17 October 2017

title

Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy (English)

1 reference

17 October 2017

1 reference

Leonardo Calza

1

1 reference

17 October 2017

Roberto Manfredi

series ordinal

2

1 reference

17 October 2017

Barbara Farneti

series ordinal

3

1 reference

17 October 2017

Francesco Chiodo

series ordinal

4

1 reference

17 October 2017

publication date

1 July 2003

1 reference

International Journal of Antimicrobial Agents

17 October 2017

published in

1 reference

17 October 2017

volume

22

1 reference

17 October 2017

issue

1

1 reference

17 October 2017

page(s)

54-59

1 reference

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Management of dyslipidemia in patients with HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Alterations in serum levels of lipids and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

"Buffalo hump" in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Disorders of fat distribution in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Severe premature coronary artery disease with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Coronary artery disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Myocardial infarction in HIV-infected men receiving protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Vascular complications associated with use of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Vascular complications associated with use of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Abdominal adiposity and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Mechanism of action of gemfibrozil on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900100-6

7 January 2021

10.1016/S0924-8579(03)00100-6

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cpr2cdqepvesvhdmk3nlo4mh4a

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_cpr2cdqepvesvhdmk3nlo4mh4a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cpr2cdqepvesvhdmk3nlo4mh4a

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/cpr2cdqepvesvhdmk3nlo4mh4a

1 reference

30 July 2022